Occurrence of respiratory viruses and nasal colonization by antibiotic-resistant bacteria in individuals with HIV in Ghana - Takeaways - MDSpire

Occurrence of respiratory viruses and nasal colonization by antibiotic-resistant bacteria in individuals with HIV in Ghana

  • By

  • Mildred Asumamaa Adusei-Poku

  • Lawrencia Ami Emefa Ativi

  • Hawawu Ahmed Zakariah

  • Evelyn Yayra Bonney

  • Ivy Asantewaa Asante

  • Nicholas T. K. D. Dayie

  • George Boateng Kyei

  • Justice Kwesi Danso

  • Agnes Oclu

  • Esimebia Amegashie

  • Osbourne Quaye

  • Elijah Paintsil

  • Kwasi Torpey

  • Beverly Egyir

  • February 14, 2026

  • 0 min

Share

  • 1

    HIV infection remains a significant global health challenge, particularly in sub-Saharan Africa, where 25 million people are affected.

  • 2

    Respiratory infections account for 70% of opportunistic infections in PLWH and contribute to over 50% of HIV-related mortality in sub-Saharan Africa.

  • 3

    This study recruited 240 participants from HIV outpatient departments to assess the prevalence of respiratory viruses and antibiotic-resistant bacteria.

  • 4

    Viral pathogens are the predominant causes of respiratory infections, which can lead to severe complications in immunocompromised individuals.

  • 5

    The study utilized advanced laboratory techniques, including RT-qPCR and antimicrobial susceptibility testing, to analyze respiratory samples.

Original Source(s)

Occurrence of respiratory viruses and nasal colonization by antibiotic-resistant bacteria in individuals with HIV in Ghana

  • by Mildred Asumamaa Adusei-Poku, Lawrencia Ami Emefa Ativi, Hawawu Ahmed Zakariah, Evelyn Yayra Bonney, Ivy Asantewaa Asante, Nicholas T. K. D. Dayie, George Boateng Kyei, Justice Kwesi Danso, Agnes Oclu, Esimebia Amegashie, Osbourne Quaye, Elijah Paintsil, Kwasi Torpey, Beverly Egyir

  • February 14, 2026

Related Content

Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults: A Cluster Randomized Crossover Study

Antivirals Linked to Lower Hospitalization in Influenza

Matched cohort study in nonhospitalized patients

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.